Literature DB >> 2767081

A rapid method for the determination of human CEA/mouse anti-CEA immune complexes in patients undergoing immunoscintigraphy.

R P Baum1, P H Driever, D Drahovsky, G Hör.   

Abstract

We report here on a new and quick procedure to isolate human (hu) CEA mouse anti CEA immune complexes of sera from patients admitted for immunoscintigraphy with radiolabeled monoclonal anti CEA antibody. This method employs rabbit anti mouse IgG immune affinity chromatography together with a commercial CEA-IRMA kit for the specific isolation of immune complexes. By applying this procedure we were able to show that immune complex formation increased in parallel to CEA serum concentration. The formation of immune complexes did not significantly affect tumor detection by immunoscintigraphy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767081     DOI: 10.1007/BF00435473

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  17 in total

1.  The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies.

Authors:  D PRESSMAN; L KORNGOLD
Journal:  Cancer       Date:  1953-05       Impact factor: 6.860

2.  Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography.

Authors:  D Pressman; T M Chu; A L Grossberg
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

3.  Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.

Authors:  J P Mach; J F Chatal; J D Lumbroso; F Buchegger; M Forni; J Ritschard; C Berche; J Y Douillard; S Carrel; M Herlyn
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

4.  Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.

Authors:  D M Goldenberg; F DeLand; E Kim; S Bennett; F J Primus; J R van Nagell; N Estes; P DeSimone; P Rayburn
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

5.  Monoclonal antibodies to carcinoembryonic antigen produced by somatic cell fusion.

Authors:  H Z Kupchik; V R Zurawski; J G Hurrell; N Zamcheck; P H Black
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

6.  Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.

Authors:  G L Buraggi; L Callegaro; G Mariani; A Turrin; N Cascinelli; A Attili; E Bombardieri; G Terno; G Plassio; M Dovis
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

7.  Immunoscintigraphy of colon carcinoma.

Authors:  J F Chatal; J C Saccavini; P Fumoleau; J Y Douillard; C Curtet; M Kremer; B Le Mevel; H Koprowski
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

8.  Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen.

Authors:  F J Primus; S J Bennett; E E Kim; F H DeLand; M C Zahn; D M Goldenberg
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

9.  Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation.

Authors:  J P Mach; S Carrel; M Forni; J Ritschard; A Donath; P Alberto
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

10.  Specific carcinoembryonic antigens of the human digestive system.

Authors:  P Gold; S O Freedman
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  2 in total

1.  Nuclear medicine 2000.

Authors:  O Schober
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Immunoscintigraphy for cancer detection: "a thousand ills require a thousand cures".

Authors:  S H de Bie; T C Ferreira; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.